Dr. Anitha T.S’s research is centered on cancer biology and therapeutics, with a primary focus on glioblastoma and hepatocellular carcinoma. She also explores the emerging impact of microplastics on cancer progression. Her work aims to develop translational cancer therapies by investigating novel drug-targetable signaling pathways and the role of oxidative stress in tumor development.
She completed her Ph.D. at the Department of Animal Sciences, School of Life Sciences, Bharathidasan University, where she studied the molecular basis of oxidative stress-induced cataractogenesis and the impact of traditional therapeutic interventions. She began her scientific research career in 2015 as a Scientist at the Central Inter-Disciplinary Research Facility (CIDRF), Sri Balaji Vidyapeeth (Deemed to-be University), Puducherry, where she spent seven years investigating drug repurposing strategies for glioma, focusing on therapeutic efficacy and synergy with standard treatments.
In 2022, she joined Pondicherry University as an Assistant Professor, where she is actively engaged in both teaching and research. Her current research aims to translate foundational scientific discoveries into molecular medicine for cancer treatment, with the broader goal of improving patient outcomes and survival rates. Her expertise includes both in vitro and in vivo preclinical cancer models, particularly xenograft-induced cancer models, and she has published her findings in reputed peer-reviewed journals such as Scientific Reports, Frontiers in Pharmacology, Life Sciences etc. She has received research funding from both institutional and national bodies, including the Indian Council of Medical Research (ICMR) and the Department of Science, Technology, and Environment (DSTE), Government of Puducherry and maintains collaborations with national and international research groups and R&D labs.
In 2024, she was awarded the ICMR-DHR Long-term International Fellowship for Young Biomedical Scientists and received advanced research training at the University of Paris-Est Créteil, France, where she gained hands-on experience in using the chick embryo model for drug toxicity studies and as a cancer research model. She is also actively involved in academia–industry collaborative projects in cancer research.